Let's talk medical research

Many factors play into running a successful clinical trial. Patient recruitment has an infamous reputation for taking a long time and slowing down the research process. However, with the right patient recruitment strategies, enrolling volunteers doesn’t have to halt your trial’s progress.

A major challenge in clinical trial advertising is being creative within the scope of institutional review board (IRB) and FDA guidelines, as well as distribution channel rules. While it can take more time and research to craft copy within such narrow parameters, it is definitely still possible to engage patients without breaking the rules.

The Hepatitis B Foundation is a national nonprofit organization dedicated to finding a cure and improving the quality of life for those affected by hepatitis B worldwide. We’re proud to partner with them to help people living with hepatitis B find and take part in clinical trials.

When it comes to running a clinical trial, researchers have been getting creative, trading traditional processes for virtual opportunities. This has become especially apparent in light of the COVID-19 pandemic.

Hepatitis B is a liver infection caused by the hepatitis B virus (HBV). For some, hepatitis B can be a short-term illness, but for others, it can become a chronic condition that can lead to serious health issues like cirrhosis or liver cancer. The best way to prevent hepatitis B is by getting vaccinated, which usually occurs shortly after birth.

Ulcerative colitis, a common form of inflammatory bowel disease (IBD), is characterized by continuous inflammation of the colon. There is no known cure for ulcerative colitis and flare-ups may recur. That’s why scientists are actively researching treatments and therapies for people living with ulcerative colitis.

Finding the right people to participate in clinical trials is no easy task, but with the right approach, sponsors can hit the sweet spot in reaching their recruitment goals.

Autoimmune hepatitis (AIH) is a rare disease in which the body's immune system attacks the cells of the liver. Like other autoimmune diseases, researchers don't know what causes autoimmune hepatitis for the approximately 100,000-200,000 people living with the condition in the U.S.

With technology advancing at a rapid pace, clinical trial sponsors and sites have been forced to rethink the avenues they use to optimize clinical trials. This has become especially apparent during the COVID-19 pandemic — for clinical trials to stay on track, they have to adopt new ways of conducting research while maintaining data integrity and patient safety. At the same time, patient ...

A flare-up is the reappearance of disease symptoms. And for people living with ulcerative colitis (UC), an inflammatory bowel disease (IBD), flare-ups can be unpredictable, lasting hours, days, or weeks.